Physician profile
Jared Hart
NPI 1437611324
$7,070.83
in general payments reported to CMS, 2019-2025
27 companies · $1,591 in 2025
The $1,591 reported for 2025 was more than what 79% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $111 · 2022: $2,474 · 2023: $1,581 · 2024: $1,314 · 2025: $1,591.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,486.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,485.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,360.32 | 2022-2023 | Ortholoc 2 Lapifuse, Inbone |
| Organogenesis INC. | $2,310.69 | 2023-2025 | Puraply, Puraply Wound Matrix, Nushield |
| Smith+Nephew, INC. | $716.29 | 2022-2025 | Grafix Pl, Versajet, Stravix Pl |
| Kerecis Limited | $261.75 | 2023-2025 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Surgiclose |
| Treace Medical Concepts, INC. | $172.68 | 2024 | |
| Integra Lifesciences Corporation | $163.22 | 2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Acera Surgical, INC. | $151.62 | 2023-2025 | Restrata Wound Matrix |
| Horizon Therapeutics Plc | $128.68 | 2021-2023 | Krystexxa |
| Depuy Synthes Sales INC. | $107.62 | 2022-2025 | Motoband, Na |
| Medline Industries LP | $88.72 | 2023 | |
| Encore Medical, LP | $76.31 | 2022 | |
| Paratek Pharmaceuticals, INC. | $61.28 | 2024-2025 | Nuzyra |
| Polynovo North America LLC | $58.45 | 2023-2025 | Novosorb Btm |
| Paragon 28, INC. | $53.86 | 2024-2025 | Tenotac, Mtp |
| Mimedx Group, INC. | $37.75 | 2024-2025 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $37.13 | 2024 | |
| Melinta Therapeutics, LLC | $37.11 | 2022 | |
| Ets Wound Care LLC | $36.75 | 2024 | Mirragen Advanced Wound Matrix |
| Biocomposites INC | $31.95 | 2024 | |
| Solventum Corporation | $31.80 | 2025 | Activ.A.C., Prevena |
| Amgen INC. | $31.07 | 2024-2025 | Krystexxa |
| Nevro Corp. | $22.32 | 2023 | Senza |
| Sanara Medtech INC. | $22.16 | 2025 | Celleraterx |
| Boston Scientific Corporation | $19.74 | 2024 | |
| Orthofix Medical, INC. | $18.71 | 2024 | Physio-Stim |
| Next Science LLC | $17.07 | 2023 | Xperience, Blastx, Surgx |
| Djo, LLC | $15.78 | 2024 | Cmf |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jared Hart listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.